Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective study
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Cancer Research and Clinical Oncology"
DOI: 10.1007/s00432-021-03767-4
Abstract: The aim of this retrospective study was to compare the clinical outcomes of pembrolizumab-lenvatinib-transarterial chemoembolization (TACE) versus lenvatinib-TACE sequential therapy in selected populations of Chinese patients with initially unresectable hepatocellular carcinoma (uHCC) harbouring programmed cell… read more here.
Keywords: tace; lenvatinib tace; tace group; study ... See more keywords
Comparison of TACE alone versus TACE combined with synchronous ablation for neuroendocrine neoplasms with liver metastases
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Cancer Research and Clinical Oncology"
DOI: 10.1007/s00432-025-06274-y
Abstract: To compare the efficacy and safety between thermal ablation combined with synchronous TACE and TACE in patients with liver metastasis of neuroendocrine tumors of different pathologic grades and different primary sites. A retrospective analysis was… read more here.
Keywords: synchronous ablation; tace group; tace; ablation ... See more keywords
Efficacy and safety of transarterial chemoembolization combined with targeted therapy and immunotherapy versus with targeted monotherapy in unresectable hepatocellular carcinoma: A systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2024 at "Medicine"
DOI: 10.1097/md.0000000000038037
Abstract: Background and objective: The application of transarterial chemoembolization (TACE) in combination with targeted therapy and immunotherapy (TACE-T-I) for unresectable hepatocellular carcinoma (HCC) has gained increasing attention. However, there are variations in the efficacy and safety… read more here.
Keywords: tace group; tace; combined targeted; targeted therapy ... See more keywords
Evaluation of Transarterial Chemoembolization Protocol with Drug-Eluting Beads in Combination with Lipiodol for Hepatocellular Carcinoma: A Single-Center Controlled Study
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Oncology"
DOI: 10.1155/2022/1090313
Abstract: Objectives To evaluate the efficacy and safety of transarterial chemoembolization (TACE) with drug-eluting beads (DEB-TACE) and lipiodol (DEB-Lipiodol TACE) in the treatment of unresectable hepatocellular carcinoma (HCC) patients. Materials and Methods The medical records of… read more here.
Keywords: tace; months months; deb lipiodol; lipiodol tace ... See more keywords
Transarterial chemoembolization (TACE) combined with camrelizumab and apatinib versus TACE alone in the treatment of unresectable hepatocellular carcinoma eligible for embolization: A multicenter, open-label, randomized, phase 2 study (CAP-ACE).
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.4_suppl.lba522
Abstract: LBA522 Background: Transarterial chemoembolization (TACE) has been established as a standard treatment for hepatocellular carcinoma (HCC) eligible for embolization. Combining immunotherapy and tyrosine kinase inhibitors (TKIs) with TACE can potentially enhance antitumor activity by activating… read more here.
Keywords: tace group; camrelizumab apatinib; tace; group ... See more keywords
Transarterial chemoembolization using drug-eluting beads versus lipiodol in the treatment of unresectable hepatocellular carcinoma: propensity score matching
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Gastrointestinal Oncology"
DOI: 10.21037/jgo-24-369
Abstract: Background Since the introduction of drug-eluting beads (DEB), the result comparing transarterial chemoembolization (TACE) using lipiodol, also called conventional transarterial chemoembolization (c-TACE), and DEB-TACE shows considerable controversy. The objective of this study was to compare… read more here.
Keywords: tace group; tace; deb tace; transarterial chemoembolization ... See more keywords
Transarterial chemoembolization in combination with lenvatinib and sintilimab for the treatment of unresectable hepatocellular carcinoma with arterioportal shunts: a retrospective analysis
Sign Up to like & getrecommendations! Published in 2025 at "Translational Cancer Research"
DOI: 10.21037/tcr-2025-167
Abstract: Background The efficacy of transarterial chemoembolization (TACE) in treating unresectable hepatocellular carcinoma (uHCC) complicated by arterioportal shunts (APS) was unsatisfactory. Developed systemic therapies can synergize with TACE, potentially reducing APS recanalization and enhancing patient benefits.… read more here.
Keywords: treatment; tace group; tace; unresectable hepatocellular ... See more keywords
Efficacy and Safety of Lobaplatin-TACE in the Treatment of Primary Hepatocellular Carcinoma: A Retrospective Study
Sign Up to like & getrecommendations! Published in 2022 at "Anti-Cancer Agents in Medicinal Chemistry"
DOI: 10.2174/1871520622666220601115458
Abstract: Purpose To investigate the safety and efficacy of lobaplatin-TACE in treating primary hepatocellular carcinoma. Methods The data of 536 patients who underwent TACE in the interventional department from January 2016 to January 2020 were collected.… read more here.
Keywords: epirubicin tace; tace; tace group; lobaplatin tace ... See more keywords
Comparison of CalliSpheres® Microspheres Drug-eluting Beads and Conventional Transarterial Chemoembolization in Hepatocellular Carcinoma Patients: A Randomized Controlled Trial
Sign Up to like & getrecommendations! Published in 2023 at "Radiology and Oncology"
DOI: 10.2478/raon-2023-0001
Abstract: Abstract Background This trial aimed to compare the outcomes of drug-eluting beads transarterial chemoembolization (DEB-TACE) with CalliSpheres® microspheres (CSM) and conventional transarterial chemoembolization cTACE in the treatment of patients with unresectable hepatocellular carcinoma (HCC). Patients… read more here.
Keywords: deb tace; ctace group; group; transarterial chemoembolization ... See more keywords
Apatinib Plus Camrelizumab With/Without Chemoembolization for Hepatocellular Carcinoma: A Real-World Experience of a Single Center
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.835889
Abstract: Objective This study was conducted in order to compare the efficacy and safety of transarterial chemoembolization (TACE) plus apatinib plus camrelizumab (TACE+AC) and apatinib plus camrelizumab (AC) in the treatment of unresectable hepatocellular carcinoma (HCC)… read more here.
Keywords: hepatocellular carcinoma; plus camrelizumab; apatinib plus; group ... See more keywords
Transarterial chemoembolization plus apatinib with or without camrelizumab for unresected hepatocellular carcinoma: A two-center propensity score matching study
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.1057560
Abstract: Purpose To compare the effectiveness and safety of transarterial chemoembolization (TACE) combined with apatinib and camrelizumab with those of TACE as well as apatinib among patients with unresectable hepatocellular carcinoma (HCC). Materials and methods The… read more here.
Keywords: hepatocellular carcinoma; tace; camrelizumab; tace group ... See more keywords